お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、注意欠陥多動性障害（ADHD）の治療の世界市場、容量、生産量、収益、価格の概要を紹介します。2020~2024年の歴史的な市場収益/売上データ、2025年の予想、および2031年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に注意欠陥多動性障害（ADHD）の治療市場を分類しています。
本レポートでは世界の注意欠陥多動性障害（ADHD）の治療市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：akeda Pharmaceutical Company Limited、Aytu BioPharma, Inc.、Eli Lilly and Company、Pfizer Inc.、Noven Pharmaceuticals Inc.、Alcobra Ltd.、Supernus Pharmaceuticals, Inc.、Johnson & Johnson Services Inc.、Novartis AG、Curemark, LLC、Impax Laboratories, LLC、GlaxoSmithKline Plc、Neos Therapeutics, Inc.、Highland Therapeutics Inc.、Advanz Pharmaceutical Corp

レポートは注意欠陥多動性障害（ADHD）の治療の主要生産者を調査し、主要地域や国の消費状況も提供します。注意欠陥多動性障害（ADHD）の治療の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2020年から2031年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Stimulant
    Non-Stimulant

用途別の市場セグメント：
    Hospital Pharmacy
    Retail Pharmacy

本レポートの詳細内容
本レポートは、世界の注意欠陥多動性障害（ADHD）の治療市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて注意欠陥多動性障害（ADHD）の治療市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2020年から2025年まで、そして2031年までの予測として、メーカー別、地域別（地域レベル、国レベル）の注意欠陥多動性障害（ADHD）の治療生産量、成長率、市場シェアを調査している。

二. 消費面では、注意欠陥多動性障害（ADHD）の治療の売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2020年から2025年まで、2031年までの予測。

三.主要メーカーの注意欠陥多動性障害（ADHD）の治療売上高、収益、市場シェア、業界ランキング、2020年から2025年までのデータに焦点を当てています。世界の注意欠陥多動性障害（ADHD）の治療市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本注意欠陥多動性障害（ADHD）の治療のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：注意欠陥多動性障害（ADHD）の治療のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2020～2031）
第2章： 注意欠陥多動性障害（ADHD）の治療の世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2020～2031）
第3章：世界、地域、国レベルにおける注意欠陥多動性障害（ADHD）の治療の売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2020～2031）
第4章注意欠陥多動性障害（ADHD）の治療メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2020～2025）
第5章：注意欠陥多動性障害（ADHD）の治療の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2020～2031）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2020～2031）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2020～2031）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第12章：注意欠陥多動性障害（ADHD）の治療の主要メーカーの概要を提供し、製品の説明と仕様、注意欠陥多動性障害（ADHD）の治療の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2020～2025）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：注意欠陥多動性障害（ADHD）の治療の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

The global Attention Deficit Hyperactivity Disorder (ADHD) Treatment market is projected to grow from US$ 21310 million in 2024 to US$ 29380 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period.
The US & Canada market for Attention Deficit Hyperactivity Disorder (ADHD) Treatment is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Attention Deficit Hyperactivity Disorder (ADHD) Treatment is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Attention Deficit Hyperactivity Disorder (ADHD) Treatment is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key manufacturers of Attention Deficit Hyperactivity Disorder (ADHD) Treatment include akeda Pharmaceutical Company Limited, Aytu BioPharma, Inc., Eli Lilly and Company, Pfizer Inc., Noven Pharmaceuticals Inc., Alcobra Ltd., Supernus Pharmaceuticals, Inc., Johnson & Johnson Services Inc. and Novartis AG, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Attention Deficit Hyperactivity Disorder (ADHD) Treatment, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Attention Deficit Hyperactivity Disorder (ADHD) Treatment, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Attention Deficit Hyperactivity Disorder (ADHD) Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Attention Deficit Hyperactivity Disorder (ADHD) Treatment sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Attention Deficit Hyperactivity Disorder (ADHD) Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Attention Deficit Hyperactivity Disorder (ADHD) Treatment sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including akeda Pharmaceutical Company Limited, Aytu BioPharma, Inc., Eli Lilly and Company, Pfizer Inc., Noven Pharmaceuticals Inc., Alcobra Ltd., Supernus Pharmaceuticals, Inc., Johnson & Johnson Services Inc. and Novartis AG, etc.
Market Segmentation
By Company
    akeda Pharmaceutical Company Limited
    Aytu BioPharma, Inc.
    Eli Lilly and Company
    Pfizer Inc.
    Noven Pharmaceuticals Inc.
    Alcobra Ltd.
    Supernus Pharmaceuticals, Inc.
    Johnson & Johnson Services Inc.
    Novartis AG
    Curemark, LLC
    Impax Laboratories, LLC
    GlaxoSmithKline Plc
    Neos Therapeutics, Inc.
    Highland Therapeutics Inc.
    Advanz Pharmaceutical Corp

Segment by Type
    Stimulant
    Non-Stimulant

Segment by Application
    Hospital Pharmacy
    Retail Pharmacy

Segment by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Attention Deficit Hyperactivity Disorder (ADHD) Treatment in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Attention Deficit Hyperactivity Disorder (ADHD) Treatment manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Attention Deficit Hyperactivity Disorder (ADHD) Treatment sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

List of Tables
    Table 1. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Stimulant
    Table 3. Major Manufacturers of Non-Stimulant
    Table 4. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue Market Share by Region (2019-2024)
    Table 9. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue Market Share by Region (2025-2030)
    Table 10. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Region (2019-2024) & (K Units)
    Table 12. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Region (2025-2030) & (K Units)
    Table 13. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales Market Share by Region (2019-2024)
    Table 14. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales Market Share by Region (2025-2030)
    Table 15. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Manufacturers (2019-2024) & (K Units)
    Table 16. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales Share by Manufacturers (2019-2024)
    Table 17. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of Attention Deficit Hyperactivity Disorder (ADHD) Treatment, Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Price by Manufacturers 2019-2024 (US$/Unit)
    Table 21. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Treatment as of 2023)
    Table 23. Global Key Manufacturers of Attention Deficit Hyperactivity Disorder (ADHD) Treatment, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Attention Deficit Hyperactivity Disorder (ADHD) Treatment, Product Offered and Application
    Table 25. Global Key Manufacturers of Attention Deficit Hyperactivity Disorder (ADHD) Treatment, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Type (2019-2024) & (K Units)
    Table 28. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Type (2025-2030) & (K Units)
    Table 29. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales Share by Type (2019-2024)
    Table 30. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales Share by Type (2025-2030)
    Table 31. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue Share by Type (2019-2024)
    Table 34. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue Share by Type (2025-2030)
    Table 35. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Price by Type (2019-2024) & (US$/Unit)
    Table 36. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Price Forecast by Type (2025-2030) & (US$/Unit)
    Table 37. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Application (2019-2024) & (K Units)
    Table 38. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Application (2025-2030) & (K Units)
    Table 39. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales Share by Application (2019-2024)
    Table 40. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales Share by Application (2025-2030)
    Table 41. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue Share by Application (2019-2024)
    Table 44. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue Share by Application (2025-2030)
    Table 45. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Price by Application (2019-2024) & (US$/Unit)
    Table 46. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Price Forecast by Application (2025-2030) & (US$/Unit)
    Table 47. US & Canada Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Type (2019-2024) & (K Units)
    Table 48. US & Canada Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Type (2025-2030) & (K Units)
    Table 49. US & Canada Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Application (2019-2024) & (K Units)
    Table 52. US & Canada Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Application (2025-2030) & (K Units)
    Table 53. US & Canada Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Application (2019-2024) & (US$ Million)
    Table 54. US & Canada Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Application (2025-2030) & (US$ Million)
    Table 55. US & Canada Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Country (2019-2024) & (K Units)
    Table 59. US & Canada Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Country (2025-2030) & (K Units)
    Table 60. Europe Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Type (2019-2024) & (K Units)
    Table 61. Europe Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Type (2025-2030) & (K Units)
    Table 62. Europe Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Application (2019-2024) & (K Units)
    Table 65. Europe Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Application (2025-2030) & (K Units)
    Table 66. Europe Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Application (2019-2024) & (US$ Million)
    Table 67. Europe Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Application (2025-2030) & (US$ Million)
    Table 68. Europe Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Country (2019-2024) & (K Units)
    Table 72. Europe Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Country (2025-2030) & (K Units)
    Table 73. China Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Type (2019-2024) & (K Units)
    Table 74. China Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Type (2025-2030) & (K Units)
    Table 75. China Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Application (2019-2024) & (K Units)
    Table 78. China Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Application (2025-2030) & (K Units)
    Table 79. China Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Application (2019-2024) & (US$ Million)
    Table 80. China Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Application (2025-2030) & (US$ Million)
    Table 81. Asia Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Type (2019-2024) & (K Units)
    Table 82. Asia Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Type (2025-2030) & (K Units)
    Table 83. Asia Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Application (2019-2024) & (K Units)
    Table 86. Asia Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Application (2025-2030) & (K Units)
    Table 87. Asia Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Application (2019-2024) & (US$ Million)
    Table 88. Asia Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Region (2019-2024) & (K Units)
    Table 93. Asia Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Region (2025-2030) & (K Units)
    Table 94. Middle East, Africa and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Type (2019-2024) & (K Units)
    Table 95. Middle East, Africa and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Type (2025-2030) & (K Units)
    Table 96. Middle East, Africa and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Application (2019-2024) & (K Units)
    Table 99. Middle East, Africa and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Application (2025-2030) & (K Units)
    Table 100. Middle East, Africa and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Application (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Application (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Country (2019-2024) & (K Units)
    Table 106. Middle East, Africa and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales by Country (2025-2030) & (K Units)
    Table 107. akeda Pharmaceutical Company Limited Company Information
    Table 108. akeda Pharmaceutical Company Limited Description and Major Businesses
    Table 109. akeda Pharmaceutical Company Limited Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. akeda Pharmaceutical Company Limited Attention Deficit Hyperactivity Disorder (ADHD) Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. akeda Pharmaceutical Company Limited Recent Developments
    Table 112. Aytu BioPharma, Inc. Company Information
    Table 113. Aytu BioPharma, Inc. Description and Major Businesses
    Table 114. Aytu BioPharma, Inc. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Aytu BioPharma, Inc. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Aytu BioPharma, Inc. Recent Developments
    Table 117. Eli Lilly and Company Company Information
    Table 118. Eli Lilly and Company Description and Major Businesses
    Table 119. Eli Lilly and Company Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Eli Lilly and Company Attention Deficit Hyperactivity Disorder (ADHD) Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Eli Lilly and Company Recent Developments
    Table 122. Pfizer Inc. Company Information
    Table 123. Pfizer Inc. Description and Major Businesses
    Table 124. Pfizer Inc. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Pfizer Inc. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Pfizer Inc. Recent Developments
    Table 127. Noven Pharmaceuticals Inc. Company Information
    Table 128. Noven Pharmaceuticals Inc. Description and Major Businesses
    Table 129. Noven Pharmaceuticals Inc. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Noven Pharmaceuticals Inc. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Noven Pharmaceuticals Inc. Recent Developments
    Table 132. Alcobra Ltd. Company Information
    Table 133. Alcobra Ltd. Description and Major Businesses
    Table 134. Alcobra Ltd. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. Alcobra Ltd. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Alcobra Ltd. Recent Developments
    Table 137. Supernus Pharmaceuticals, Inc. Company Information
    Table 138. Supernus Pharmaceuticals, Inc. Description and Major Businesses
    Table 139. Supernus Pharmaceuticals, Inc. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 140. Supernus Pharmaceuticals, Inc. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Supernus Pharmaceuticals, Inc. Recent Developments
    Table 142. Johnson & Johnson Services Inc. Company Information
    Table 143. Johnson & Johnson Services Inc. Description and Major Businesses
    Table 144. Johnson & Johnson Services Inc. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 145. Johnson & Johnson Services Inc. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Johnson & Johnson Services Inc. Recent Developments
    Table 147. Novartis AG Company Information
    Table 148. Novartis AG Description and Major Businesses
    Table 149. Novartis AG Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 150. Novartis AG Attention Deficit Hyperactivity Disorder (ADHD) Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Novartis AG Recent Developments
    Table 152. Curemark, LLC Company Information
    Table 153. Curemark, LLC Description and Major Businesses
    Table 154. Curemark, LLC Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 155. Curemark, LLC Attention Deficit Hyperactivity Disorder (ADHD) Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Curemark, LLC Recent Developments
    Table 157. Impax Laboratories, LLC Company Information
    Table 158. Impax Laboratories, LLC Description and Major Businesses
    Table 159. Impax Laboratories, LLC Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 160. Impax Laboratories, LLC Attention Deficit Hyperactivity Disorder (ADHD) Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. Impax Laboratories, LLC Recent Developments
    Table 162. GlaxoSmithKline Plc Company Information
    Table 163. GlaxoSmithKline Plc Description and Major Businesses
    Table 164. GlaxoSmithKline Plc Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 165. GlaxoSmithKline Plc Attention Deficit Hyperactivity Disorder (ADHD) Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    Table 166. GlaxoSmithKline Plc Recent Developments
    Table 167. Neos Therapeutics, Inc. Company Information
    Table 168. Neos Therapeutics, Inc. Description and Major Businesses
    Table 169. Neos Therapeutics, Inc. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 170. Neos Therapeutics, Inc. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    Table 171. Neos Therapeutics, Inc. Recent Developments
    Table 172. Highland Therapeutics Inc. Company Information
    Table 173. Highland Therapeutics Inc. Description and Major Businesses
    Table 174. Highland Therapeutics Inc. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 175. Highland Therapeutics Inc. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    Table 176. Highland Therapeutics Inc. Recent Developments
    Table 177. Advanz Pharmaceutical Corp Company Information
    Table 178. Advanz Pharmaceutical Corp Description and Major Businesses
    Table 179. Advanz Pharmaceutical Corp Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 180. Advanz Pharmaceutical Corp Attention Deficit Hyperactivity Disorder (ADHD) Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    Table 181. Advanz Pharmaceutical Corp Recent Developments
    Table 182. Key Raw Materials Lists
    Table 183. Raw Materials Key Suppliers Lists
    Table 184. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Distributors List
    Table 185. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Customers List
    Table 186. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Trends
    Table 187. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Drivers
    Table 188. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Challenges
    Table 189. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Restraints
    Table 190. Research Programs/Design for This Report
    Table 191. Key Data Information from Secondary Sources
    Table 192. Key Data Information from Primary Sources
List of Figures
    Figure 1. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Product Picture
    Figure 2. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Share by Type in 2023 & 2030
    Figure 4. Stimulant Product Picture
    Figure 5. Non-Stimulant Product Picture
    Figure 6. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Share by Application in 2023 & 2030
    Figure 8. Hospital Pharmacy
    Figure 9. Retail Pharmacy
    Figure 10. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Report Years Considered
    Figure 11. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue 2019-2030 (US$ Million)
    Figure 13. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 14. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue Market Share by Region (2019-2030)
    Figure 15. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales 2019-2030 ((K Units)
    Figure 16. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales Market Share by Region (2019-2030)
    Figure 17. US & Canada Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales YoY (2019-2030) & (K Units)
    Figure 18. US & Canada Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue YoY (2019-2030) & (US$ Million)
    Figure 19. Europe Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales YoY (2019-2030) & (K Units)
    Figure 20. Europe Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue YoY (2019-2030) & (US$ Million)
    Figure 21. China Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales YoY (2019-2030) & (K Units)
    Figure 22. China Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. Asia (excluding China) Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales YoY (2019-2030) & (K Units)
    Figure 24. Asia (excluding China) Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Middle East, Africa and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales YoY (2019-2030) & (K Units)
    Figure 26. Middle East, Africa and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. The Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 28. The Top 5 and 10 Largest Manufacturers of Attention Deficit Hyperactivity Disorder (ADHD) Treatment in the World: Market Share by Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue in 2023
    Figure 29. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 30. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales Market Share by Type (2019-2030)
    Figure 31. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue Market Share by Type (2019-2030)
    Figure 32. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales Market Share by Application (2019-2030)
    Figure 33. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue Market Share by Application (2019-2030)
    Figure 34. US & Canada Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales Market Share by Type (2019-2030)
    Figure 35. US & Canada Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue Market Share by Type (2019-2030)
    Figure 36. US & Canada Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales Market Share by Application (2019-2030)
    Figure 37. US & Canada Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue Market Share by Application (2019-2030)
    Figure 38. US & Canada Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue Share by Country (2019-2030)
    Figure 39. US & Canada Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales Share by Country (2019-2030)
    Figure 40. U.S. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue (2019-2030) & (US$ Million)
    Figure 41. Canada Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue (2019-2030) & (US$ Million)
    Figure 42. Europe Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales Market Share by Type (2019-2030)
    Figure 43. Europe Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue Market Share by Type (2019-2030)
    Figure 44. Europe Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales Market Share by Application (2019-2030)
    Figure 45. Europe Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue Market Share by Application (2019-2030)
    Figure 46. Europe Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue Share by Country (2019-2030)
    Figure 47. Europe Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales Share by Country (2019-2030)
    Figure 48. Germany Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue (2019-2030) & (US$ Million)
    Figure 49. France Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue (2019-2030) & (US$ Million)
    Figure 50. U.K. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue (2019-2030) & (US$ Million)
    Figure 51. Italy Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue (2019-2030) & (US$ Million)
    Figure 52. Russia Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue (2019-2030) & (US$ Million)
    Figure 53. China Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales Market Share by Type (2019-2030)
    Figure 54. China Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue Market Share by Type (2019-2030)
    Figure 55. China Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales Market Share by Application (2019-2030)
    Figure 56. China Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue Market Share by Application (2019-2030)
    Figure 57. Asia Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales Market Share by Type (2019-2030)
    Figure 58. Asia Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue Market Share by Type (2019-2030)
    Figure 59. Asia Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales Market Share by Application (2019-2030)
    Figure 60. Asia Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue Market Share by Application (2019-2030)
    Figure 61. Asia Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue Share by Region (2019-2030)
    Figure 62. Asia Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales Share by Region (2019-2030)
    Figure 63. Japan Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue (2019-2030) & (US$ Million)
    Figure 64. South Korea Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue (2019-2030) & (US$ Million)
    Figure 65. China Taiwan Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue (2019-2030) & (US$ Million)
    Figure 66. Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue (2019-2030) & (US$ Million)
    Figure 67. India Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue (2019-2030) & (US$ Million)
    Figure 68. Middle East, Africa and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales Market Share by Type (2019-2030)
    Figure 69. Middle East, Africa and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue Market Share by Type (2019-2030)
    Figure 70. Middle East, Africa and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Sales Market Share by Application (2019-2030)
    Figure 71. Middle East, Africa and Latin America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue Mark